Articles

AMD supplants Nvidia as this analyst’s top chip stock — but he still likes both

AMD’s stock advances as Wolfe Research writes positively of the company’s AI traction.

Fed’s Mester says her businesses contacts are sensing the economy is stronger than anticipated

Business contacts in the Midwest are starting to become much more upbeat about where the economy is going, Cleveland Federal Reserve Bank President Loretta Mester said on Thursday.

Mortgage rates fall to the lowest level in a month, but ‘home buyers are still feeling the pressure’ from high home prices

The 30-year mortgage rate is averaging at 7.02% Freddie Mac said in its latest weekly survey on Thursday.

Jamie Dimon sees ‘happy talk’ driving markets as he maintains cautious view

JPMorgan Chase chief executive is sticking to his outlook that a soft landing for the economy is less likely than markets expect.

Our adviser put 50% of our holdings in individual stocks, but now we fear a big tax hit by switching to index funds

Changing investment strategies midstream can lead to significant capital gains when you sell.

Fed’s Barkin: Service companies are still trying to raise prices

The service sector “has changed their view” and believes consumers will accept higher prices and are going to raise them until households balk.

Dow Jones tops 40,000 for first time, on track to deliver ‘psychological boost’ to bulls

The Dow Jones Industrial Average traded above 40,000 for first time ever on Thursday.

Intel’s stock has fallen far enough, this analyst says

Wolfe Research ends its bearish call while noting that challenges remain for Intel.

U.S. industrial output flat in April

Industrial production was flat in April, the Federal Reserve reported Thursday.

Charles Schwab names ex-Citi exec as next CFO after exit of three top managers

Upper-echelon managers to step down after four-year effort to complete Ameritrade integration.

Import prices post biggest increase in two years and add to U.S. inflation pressures

The cost of imported goods rose in April for the fourth month in a row and increased at the fastest pace in two years, reflecting the persistence of elevated U.S. inflation.

Roche ramps up obesity-drug competition with early-stage trial results

The race to develop powerful new weight-loss drugs grew even more heated on Thursday as Roche Holding released early-stage trial results for an experimental obesity treatment.
1 1,399 1,400 1,401 1,402 1,403 2,560